Similar to the study on luteolin [20], a dose of 40 mg/kg TMF significantly improves AD pathology and cognitive function in APP/PS1 mice, while 10 mg/kg TMF does not yield comparable results. This evidence concerns the gene APP and Alzheimer disease.